The world of cannabinoids is vast and ever-expanding, with more compounds being discovered and studied each year. While THC and CBD have stolen much of the spotlight, a lesser-known cannabinoid, CBG (Cannabigerol), is beginning to emerge as a powerful player in the cannabis and hemp industries. But what exactly is CBG, and why is it generating so much buzz? Let’s dive in.

What is CBG?

CBG, or cannabigerol, is one of over 100 cannabinoids found in cannabis plants. It is often referred to as the “mother of all cannabinoids” because it is the precursor to other major cannabinoids, including THC, CBD, and CBC. In the cannabis plant, CBGA (cannabigerolic acid) is the acidic form of CBG and the building block from which these other cannabinoids are synthesized.

As the plant matures, enzymes convert CBGA into THCA, CBDA, and CBCA, which eventually transform into THC, CBD, and CBC when exposed to heat or light. Only a small amount of CBG remains in its natural form, making it a rare and valuable compound.

How is CBG Made?

Because CBG is typically present in cannabis plants in low concentrations—usually less than 1%—extracting it can be challenging and expensive. However, breeders are developing cannabis strains with higher CBG content, and advanced extraction methods are making it easier to isolate this cannabinoid.

CBG is usually extracted from young cannabis plants because CBGA, its precursor, has not yet been fully converted into other cannabinoids.

How Does CBG Work in the Body?

Like other cannabinoids, CBG interacts with the endocannabinoid system (ECS), a network of receptors (CB1 and CB2) that helps regulate various physiological processes such as mood, appetite, sleep, and immune response.

CBG has been found to bind to both CB1 and CB2 receptors, potentially influencing a wide range of bodily functions. It also interacts with other receptors, such as serotonin and adrenoreceptors, which may contribute to its potential therapeutic effects.